REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr . Bata Zrt. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: DR. BATA Magyar-Kanadai Biotechnologiai Kutato Fejleszto Zrt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Dr . Bata Zrt. is a company in Hungary, with a head office in Kecskemet. The enterprise currently operates in the Research and Development in the Physical, Engineering, and Life Sciences sector. It was established on January 29, 1990. 50 (2024) employees currently work for Dr . Bata Zrt.. From the latest financial highlights, Dr . Bata Zrt. reported a net sales revenue increase of 10% in 2023. A growth of 15.21% was recorded in its total assets. In 2023, Dr . Bata Zrt.’s net profit margin decreased by 7.24%.

Headquarters
13902 hrsz.
Kecskemet; Bacs-Kiskun; Postal Code: 6000

Contact Details: Purchase the Dr . Bata Zrt. report to view the information.

Website: http://www.drbata.com

Basic Information
Total Employees:
Purchase the Dr . Bata Zrt. report to view the information.
Outstanding Shares:
Purchase the Dr . Bata Zrt. report to view the information.
Registered Capital:
Purchase the Dr . Bata Zrt. report to view the information.
Financial Auditors:
Purchase the Dr . Bata Zrt. report to view the information.
Incorporation Date:
January 29, 1990
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Dr . Bata Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10%
Total operating revenue
11.33%
Operating profit (EBIT)
-26.78%
EBITDA
-27.55%
Net Profit (Loss) for the Period
-26.6%
Total assets
15.21%
Total equity
17.95%
Operating Profit Margin (ROS)
-6.46%
Net Profit Margin
-7.24%
Return on Equity (ROE)
-9.23%
Quick Ratio
1.58%
Cash Ratio
3.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?